SHAKER INVESTMENTS LLC/OH - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHAKER INVESTMENTS LLC/OH ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,006,684
+4.7%
52,531
-1.2%
1.11%
+13.1%
Q2 2023$1,917,193
-17.1%
53,152
-12.2%
0.98%
-24.2%
Q1 2023$2,311,908
-0.8%
60,537
+47.8%
1.29%
-10.7%
Q4 2022$2,330,453
+45.5%
40,957
+1.1%
1.45%
+34.6%
Q3 2022$1,602,00040,5081.07%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders